Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Clinical trial NCT05515029 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05515029
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Myeloblastic Leukemia Biphenotypic Acute Leukemia Malignant Lymphoma Myelodysplastic Syndromes Juvenile Myelomonocytic Leukemia

Start date: 2022-08-23
Primary completion: 2024-08-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.